Researches on immune thrombocytopenia (ITP) and chronic hepatitis C have shown that there were no significant differences in Treg cell percentage, Foxp3 expression, and IL-10 production in DAPT-treated PBMCs [21, 23]. Here, IL10 is linked to autoimmune thrombocytopenic purpura.